Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma. IJBB [Internet]. 2023 Jun. 26 [cited 2026 May 15];60(1):43-54. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/3229